Cerebrospinal fluid biomarkers in human genetic transmissible spongiform encephalopathies

[1]  P. Johannsen,et al.  The diagnostic efficiency of biomarkers in sporadic Creutzfeldt-Jakob disease compared to Alzheimer's disease , 2009, Neurobiology of Aging.

[2]  J. Molinuevo,et al.  First demonstrated de novo insertion in the prion protein gene in a young patient with dementia , 2008, Journal of Neurology, Neurosurgery, and Psychiatry.

[3]  C. Rubio.  Marqués de Valdecilla , 2007 .

[4]  K. Hess,et al.  Influence of timing on CSF tests value for Creutzfeldt-Jakob disease diagnosis , 2007, Journal of Neurology.

[5]  J. Collinge,et al.  Novel mutation of the PRNP gene of a clinical CJD case , 2006, BMC infectious diseases.

[6]  H. Kretzschmar,et al.  Brain-derived proteins in the CSF, do they correlate with brain pathology in CJD? , 2006, BMC neurology.

[7]  K. Hess,et al.  CSF tests in the differential diagnosis of Creutzfeldt-Jakob disease , 2006, Neurology.

[8]  M. Sierra-Moros,et al.  Impact of the clinical context on the 14-3-3 test for the diagnosis of sporadic CJD , 2006, BMC neurology.

[9]  M. Pancorbo,et al.  Phenotypic variability in familial prion diseases due to the D178N mutation , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[10]  A. Aguzzi,et al.  Genetic prion disease: the EUROCJD experience , 2005, Human Genetics.

[11]  P. Cras,et al.  Cerebrospinal fluid biomarkers in Creutzfeldt–Jakob disease , 2005, Clinical Neurology and Neurosurgery.

[12]  M. Equestre,et al.  High incidence of genetic human transmissible spongiform encephalopathies in Italy , 2005, Neurology.

[13]  B. Maras,et al.  Creutzfeldt-Jakob disease associated with the R208H mutation in the prion protein gene , 2005, Neurology.

[14]  H. Kretzschmar,et al.  Creutzfeldt-Jakob disease associated with an R148H mutation of the prion protein gene , 2005, Neurogenetics.

[15]  H. Kretzschmar,et al.  Creutzfeldt-Jakob disease in a patient with an R208H mutation of the prion protein gene (PRNP) and a 17-kDa prion protein fragment , 2005, Acta Neuropathologica.

[16]  J. Yagüe,et al.  Clinical and genetic features of human prion diseases in Catalonia: 1993–2002 , 2004, European journal of neurology.

[17]  J. Martín,et al.  A prospective study of CSF markers in 250 patients with possible Creutzfeldt–Jakob disease , 2003, Journal of neurology, neurosurgery, and psychiatry.

[18]  Trey Sunderland,et al.  Decreased beta-amyloid1-42 and increased tau levels in cerebrospinal fluid of patients with Alzheimer disease. , 2003, JAMA.

[19]  Trey Sunderland,et al.  Decreased-Amyloid 1-42 and Increased Tau Levels in Cerebrospinal Fluid of Patients With Alzheimer Disease , 2003 .

[20]  H. Budka,et al.  Mutations of the Prion Protein Gene , 2002, Journal of Neurology.

[21]  H. Kretzschmar,et al.  [Clinically atypical CJD: diagnostic relevance of cerebrospinal fluid markers and molecular genetic analysis?]. , 2002, Deutsche medizinische Wochenschrift.

[22]  H. Tumani,et al.  Die klinisch atypische CJK: Diagnostische Bedeutung von Liquormarkern und molekulargenetischen Untersuchungen? , 2002 .

[23]  J. Wiltfang,et al.  Tau protein and 14-3-3 protein in the differential diagnosis of Creutzfeldt–Jakob disease , 2002, Neurology.

[24]  H. Budka,et al.  Mutations of the prion protein gene phenotypic spectrum. , 2002, Journal of neurology.

[25]  R. Nitrini,et al.  Familial Creutzfeldt-Jakob disease associated with a point mutation at codon 210 of the prion protein gene. , 2001, Arquivos de neuro-psiquiatria.

[26]  F. Squitieri,et al.  Mutation of the PRNP gene at codon 211 in familial Creutzfeldt-Jakob disease. , 2001, American journal of medical genetics.

[27]  H. Budka,et al.  Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt–Jakob disease , 2000, Neurology.

[28]  C. Masters,et al.  Novel prion protein gene mutation in an octogenarian with Creutzfeldt-Jakob disease. , 2000, Archives of neurology.

[29]  D. Restivo,et al.  Deafness: an unusual onset of genetic Creutzfeldt-Jakob disease , 2000, Neurological Sciences.

[30]  A. Korczyn,et al.  Preliminary evidence for anticipation in genetic E200K Creutzfeldt-Jakob disease , 1999, Neurology.

[31]  T. Kato,et al.  [Clinicopathological characteristics of Creutzfeldt-Jakob disease with a PrP V180I mutation and M129V polymorphism on different alleles]. , 1999, Rinsho shinkeigaku = Clinical neurology.

[32]  A. Giese,et al.  Phenotypic variability in fatal familial insomnia (D178N-129M) genotype , 1998, Neurology.

[33]  K. Mitsuo,et al.  [Gerstmann-Sträussler-Scheinker syndrome with a Pro102Leu mutation in the prion protein gene and atypical MRI findings, hyperthermia, tachycardia, and hyperhidrosis]. , 1998, Rinsho shinkeigaku = Clinical neurology.

[34]  R. Petersen,et al.  Prion encephalopathy with insertion of octapeptide repeats: the number of repeats determines the type of cerebellar deposits , 1998, Neuropathology and applied neurobiology.

[35]  J. Chapman,et al.  Identification in Israel of 2 Jewish Creutzfeldt — Jakob disease patients with a 178 mutation at their PrP gene , 1998, Acta neurologica Scandinavica.